Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
02/28/1990 | EP0355820A1 Antihypercholesterolemic tetrazol-1-yl compounds |
02/28/1990 | EP0355750A1 Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process |
02/28/1990 | EP0355710A2 Phenylalkylthiophenes and related compounds |
02/28/1990 | EP0355689A2 Pyrano [f] quinoline derivatives and pharmaceutical compositions containing the same |
02/28/1990 | EP0355612A2 Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
02/28/1990 | EP0355604A2 Anti-cancer activity potentiator |
02/28/1990 | EP0355453A2 Use of 3-hydroxybutyric acid as an energy source |
02/28/1990 | EP0355348A2 Superoxide dismutase composition |
02/28/1990 | EP0355331A2 Poly(aminoalkyl)aminocarbonyl aminoacyl aminodiol amino acid derivatives as anti-hypertensive agents |
02/28/1990 | EP0355245A1 Use of retrovirus reverse transcriptase inhibiting agents |
02/28/1990 | EP0355131A1 Acyl deoxyribonucleoside derivatives and uses thereof |
02/28/1990 | EP0355088A1 Sulphated polysaccharides having anti-metastatic activity |
02/27/1990 | US4904688 Psychological disorders |
02/27/1990 | CA1266271A1 2,5-diaryl tetrahydrothiophenes and analogs thereof as paf-antagonists |
02/22/1990 | WO1990001477A1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
02/22/1990 | WO1990001339A1 Detection and treatment of infectious and inflammatory lesions |
02/22/1990 | WO1990001331A1 Wound healing |
02/22/1990 | WO1990001322A1 Novel method of administering aspirin and dosage forms containing same |
02/22/1990 | WO1990001321A2 Method for treating and preventing loss of bone mass |
02/22/1990 | WO1990001316A1 Pharmaceutical and/or dietetic compositions containing l-carnitine and l-lysine |
02/22/1990 | WO1990001253A1 Aloe compositions and uses thereof |
02/21/1990 | EP0355065A1 Renin inhibitory peptides containing suleptanic acid or derivatives thereof |
02/21/1990 | EP0355041A2 Complex porphyrine compounds substituted in position 13,17 by propionic acid and propionic-acid derivatives, process for their preparation and pharmaceutical compositions containing same |
02/21/1990 | EP0354934A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum |
02/21/1990 | EP0354920A1 Amino-9,10-secosteroids |
02/21/1990 | CN1039809A Process for preparing substituted aminomethytetralins and their heterocyclic analogues |
02/21/1990 | CN1039800A N-2, 3-butadienyl tri-and tetraaminoalkane derivatives |
02/21/1990 | CN1006889B Inclusion compiex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient |
02/20/1990 | US4902719 Ornithine deficiency treatment |
02/20/1990 | US4902710 Thio-, sulfinyl-, or sulfonyl-propanamines; antidepressants, anxiolytic agents; nervous system disorders |
02/20/1990 | US4902700 Thiazole derivative and leukotriene antagonist containing the same as the effective ingredients |
02/20/1990 | US4902696 Labdane derivatives; administering with decongestant to reduce redness; vision defects |
02/20/1990 | US4902691 Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors |
02/20/1990 | US4902679 Treating bone disorders |
02/20/1990 | CA1266048A1 1-alkyl substitued benzimidazole derivatives |
02/14/1990 | EP0354881A1 Acetazolamide-related compounds, process for their preparation, and pharmaceutical composition containing the same |
02/14/1990 | EP0354848A1 Pharmaceutical and/or dietetical compositions containing L-carnitine and L-lysine |
02/14/1990 | EP0354818A2 Pharmaceutical compositions containing polyaromatic compounds as active ingredient and their use |
02/14/1990 | EP0354777A2 3-(4-Piperidine)-5-(2-sulfonylaminoethyl) indole derivatives |
02/14/1990 | EP0354714A2 Pharmaceutical compositions containing polyaromatic compounds |
02/14/1990 | EP0354689A1 Diphenylethane derivatives |
02/14/1990 | EP0354683A1 Azole derivatives |
02/14/1990 | EP0354594A2 Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process |
02/14/1990 | EP0354522A1 Use of alpha-aminoboronic acid derivatives in prevention and treatement of viral diseases |
02/14/1990 | EP0354508A2 Benzopyranol derivatives |
02/14/1990 | EP0354495A1 Alkoxy-4(1H)-pyridone derivatives, process for their preparation and their pharmaceutical use |
02/14/1990 | EP0354418A2 6-Fluoro-3,5-dihydroxycarboxylic acids and their derivatives, processes for their preparation, their use as medicaments, pharmaceutical preparations and intermediates |
02/14/1990 | EP0354323A2 Antidiabetic phosphates |
02/14/1990 | EP0354322A2 Antidiabetic alpha-substituted phosphonates |
02/14/1990 | EP0148883B1 Allopurinol prodrugs |
02/14/1990 | CN1039593A 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
02/13/1990 | US4900751 2-Pyridinyl-phenyl-sulphinyl-and-phenyl-thio-benzimidazoles having antiflammatory or gastic acid secretion inhibition activity |
02/13/1990 | US4900744 Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles |
02/13/1990 | US4900737 Isoquinoline derivatives |
02/13/1990 | US4900673 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
02/13/1990 | US4900553 Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
02/13/1990 | CA1265809A1 Process for the preparation of morphologically homogeneous forms of thiazole derivatives |
02/13/1990 | CA1265789A1 Piperazine derivatives |
02/13/1990 | CA1265787A1 Method for producing chemical compounds |
02/08/1990 | WO1990000884A1 Silicon compounds in bone treatment |
02/08/1990 | WO1989009788A3 Biosynthetic osteogenic proteins and osteogenic devices containing them |
02/08/1990 | WO1989009787A3 Osteogenic devices |
02/07/1990 | EP0354094A1 Indolone derivatives, their preparation and their therapeutical use |
02/07/1990 | EP0354042A2 Aminobenzoic-acid derivatives to reduce side effects induced by an administration of immuno-suppressant |
02/07/1990 | EP0353983A2 Lactam derivatives |
02/07/1990 | EP0353960A2 Polyspecific anti-leukocyte conjugate for detection and treatment of infectious and inflammatory lesions |
02/07/1990 | EP0353910A2 Human interferon-gamma, process for preparing said human interferon-gamma, and its use |
02/07/1990 | EP0353821A2 Antipsychotic 3-piperazinyl-benzazole derivatives |
02/07/1990 | EP0353752A1 N-2, 3-butadienyl triaminoalkane derivatives |
02/07/1990 | EP0353732A2 Fluoro-olefins, method for their preparation and their use |
02/07/1990 | EP0353474A2 Glycerin derivative and its pharmacological use |
02/07/1990 | EP0353448A1 Sulfon amides, process for their preparation and pharmaceutical preparations containing them |
02/07/1990 | EP0353416A2 Use of ajoene and ajoene derivatives as cytostatics |
02/07/1990 | EP0353262A1 New therapeutical use of h 2?-receptor-blocking compounds |
02/07/1990 | EP0191044B1 Derivatives of methylene-bisphosphonic acid, process for their preparation and a pharmaceutical composition |
02/07/1990 | CN1039424A 19-fluoro-or cyano-21-hydroxy-progesterone derivatives useful as 19-hydroxylase inhibitors |
02/07/1990 | CN1039414A Glycerin derivative and its pharmacological use |
02/07/1990 | CN1039357A Pharmaceutical composition having synergistic effect |
02/06/1990 | US4898920 Adhesive compositions, controlled release compositions and transdermal delivery device |
02/06/1990 | US4898883 1-Substituted derivatives of 4-methoxy-2,3,6-trimethylbenzene, process for their preparation and medicinal and cosmetic compositions containing them |
02/06/1990 | US4898855 Treating osteoporosis and antiinflammatory agent |
02/06/1990 | US4898852 Cyclopolgalcturonic acid composition and treatment |
02/06/1990 | CA1265520A1 Apovincaminol derivatives, process for their preparation and pharmaceutical compositions containing them |
02/06/1990 | CA1265450A1 Drug, and methods of preparing and using it for treatment of tumors |
01/31/1990 | EP0353211A1 New compounds |
01/31/1990 | EP0352960A2 Purine compounds, process for their preparation and pharmaceutical compositions |
01/31/1990 | EP0352815A1 Prodrugs of dopamine |
01/31/1990 | EP0352746A2 A composition for enhancing oxygen availability or relieving hypoxia in a mammal |
01/31/1990 | EP0352613A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds |
01/31/1990 | EP0160079B1 Method and materials for sensitizing neoplastic tissue to radiation |
01/31/1990 | EP0135181B1 Process for the production of n-alkylated dipeptides and of their esters |
01/30/1990 | US4897471 Consensus human leukocyte interferon |
01/30/1990 | US4897422 Treatment of asthma, rheumatic diseases; antiarthritic agents, antiinflammatory agents |
01/30/1990 | US4897417 Prodrugs of 3,4-hydroxy benzoyloxypropanolamines |
01/30/1990 | US4897414 Cognition activators, nervous system disorders, amnesia |
01/30/1990 | US4897395 Administering anticarcinogenic agents |
01/30/1990 | US4897394 Antiviral combinations |
01/30/1990 | US4897382 Organic amide compounds derived from nitrogenous lipids |
01/30/1990 | US4897381 Stimulated biologically active carboxylic acids bound to phosphatides; anticonvulsants; prolactin inhibitors; antileptic agents |
01/30/1990 | US4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |